David Rescott
Stock Analyst at Robert W. Baird
(3.40)
# 2,330
Out of 4,575 analysts
249
Total ratings
46.8%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintained: Buy | $610 → $500 | $337.50 | +48.15% | 18 | Jul 17, 2026 | |
| NYXH Nyxoah | Maintained: Hold | $4.62 → $2.85 | $1.40 | +103.57% | 9 | Jul 9, 2026 | |
| ABT Abbott Laboratories | Initiated Coverage: Buy | $121 | $103.06 | +17.41% | 1 | Jun 30, 2026 | |
| MDT Medtronic | Maintained: Hold | $100 → $85 | $83.21 | +2.15% | 24 | Jun 4, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $75 → $70 | $44.25 | +58.19% | 28 | May 28, 2026 | |
| HAE Haemonetics | Maintained: Buy | $81 → $67 | $78.78 | -14.95% | 6 | May 8, 2026 | |
| LIVN LivaNova | Maintained: Buy | $83 → $76 | $78.19 | -2.80% | 23 | May 7, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $168 → $140 | $72.26 | +93.74% | 7 | May 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $74 → $50 | $49.19 | +1.65% | 19 | May 5, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $104 → $83 | $74.32 | +11.68% | 13 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $281 → $225 | $195.27 | +15.23% | 9 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $175 | $109.20 | +60.26% | 30 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $28 | $16.69 | +67.77% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 | $82.63 | +5.29% | 22 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $345 → $374 | $318.73 | +17.34% | 26 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $117.90 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $26 | $16.62 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $91.35 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $18.87 | n/a | 1 | Dec 21, 2021 |
Intuitive Surgical
Jul 17, 2026
Maintained: Buy
Price Target: $610 → $500
Current: $337.50
Upside: +48.15%
Nyxoah
Jul 9, 2026
Maintained: Hold
Price Target: $4.62 → $2.85
Current: $1.40
Upside: +103.57%
Abbott Laboratories
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $121
Current: $103.06
Upside: +17.41%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $100 → $85
Current: $83.21
Upside: +2.15%
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $75 → $70
Current: $44.25
Upside: +58.19%
Haemonetics
May 8, 2026
Maintained: Buy
Price Target: $81 → $67
Current: $78.78
Upside: -14.95%
LivaNova
May 7, 2026
Maintained: Buy
Price Target: $83 → $76
Current: $78.19
Upside: -2.80%
TransMedics Group
May 6, 2026
Maintained: Buy
Price Target: $168 → $140
Current: $72.26
Upside: +93.74%
Inspire Medical Systems
May 5, 2026
Maintained: Hold
Price Target: $74 → $50
Current: $49.19
Upside: +1.65%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $104 → $83
Current: $74.32
Upside: +11.68%
May 1, 2026
Maintained: Hold
Price Target: $281 → $225
Current: $195.27
Upside: +15.23%
May 1, 2026
Maintained: Buy
Price Target: $200 → $175
Current: $109.20
Upside: +60.26%
Apr 30, 2026
Maintained: Hold
Price Target: $30 → $28
Current: $16.69
Upside: +67.77%
Apr 24, 2026
Maintained: Hold
Price Target: $87
Current: $82.63
Upside: +5.29%
Jan 15, 2026
Downgraded: Hold
Price Target: $345 → $374
Current: $318.73
Upside: +17.34%
Apr 24, 2025
Maintained: Hold
Price Target: n/a
Current: $117.90
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $17 → $26
Current: $16.62
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $145
Current: $91.35
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $75
Current: $18.87
Upside: n/a